From: Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
Author | Country | Year | Sample size (high/low PNI) | Cut-off value of PNI | Median (range) of PNI | Adjusted factors | Follow-up time (month) | Age (year)(range) | NOS score | Treatment | Stage | Survival outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Xiaoxiao Hao | China | 2017 | 125/127 | 45 | – | IPI, GPS, NLR, PNI, PI | – | 49 (16–82) | 6 | R-CHOP; CHOP/CHOP-like | I–IV | OS, PFS |
Wenjuan Yu | China | 2019 | 114/195 | 45 | 48.4 (23.9–86.2) | BMI, hemoglobin, NCCI-IPI | – | – | 7 | R-CHOP | I–IV | OS |
Se-Il Go | Korea | 2019 | 69/159 | 40 | – | Sarcopenia, albumin, ALC, BMI, IPI, B-symptoms | – | 64 (21–88) | 7 | R-CHOP | I–IV | OS, PFS |
Vlatka Periˇsa | Croatia | 2017 | 75/28 | 44.55 | 50.26 (22.91–65.3) | Age, gender, IPI ECOG-PS, LDH, Ann Arbor stage, B-symptoms | Median: 27 (range: 1–105) | 63 (22–87) | 6 | R-CHOP/ R-CHOP-like | I–IV | OS, PFS |
Qinjun Zhou | China | 2016 | 129/124 | 44.675 | - | B-symptoms, LDH, Ann Arbor stage, ECOG-PS, extra-nodal, IPI | – | 49 (19–81) | 6 | R‑CHOP | I–IV | OS, PFS |
Teng Song | China | 2019 | 44/38 | 44.15 | – | ECOG-PS, Ann Arbor stage, LDH,IPI, ALC | – | 59(23–79) | 6 | CHOP; R-CHOP | I–IV | OS |
Erina Hamada | Japan | 2020 | 38/46 | 41.3 | – | Albumin, ALC, IPI, extra-nodal ECOG-PS, LDH, gender, Ann Arbor stage, B-symptoms | Median: 39 | 84 (80–94) | 6 | R-CHOP; R-CVP; R alone; palliative | I–IV | OS |